Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Accenture
Teva
Dow
UBS
Covington
Julphar
Boehringer Ingelheim

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,808,716

« Back to Dashboard

Summary for Patent: 4,808,716
Title: 9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereof
Abstract:The invention relates to 9-(phosphonylmethoxyalkyl)adenines of the general formula I ##STR1## wherein R.sup.1 is a hydrogen atom, and alkyl group containing one to three carbon atoms, or a hydroxymethyl group, R.sup.2 is a methylene, ethylene, propylene, ethylidene, methoxyethylene, benzyloxyethylene, tetrahydropyran-2-yloxyethylene, (1-ethoxyethoxy)ethylene or 1,2-O-isopropylidene-1,2-dihydroxypropylene group the method of their preparation and utilization. Compounds of the general formula I exhibit biological effects (e.g. antiviral) or can be converted into compounds with such effects.
Inventor(s): Holy; Antonin (Praha, CS), Rosenberg; Ivan (Praha, CS)
Assignee: Ceskoslovenska akademic ved (CS)
Application Number:06/856,299
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,808,716

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,808,716

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Czechoslovakia3017-85Apr 25, 1985

International Family Members for US Patent 4,808,716

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Czechoslovakia 263951 ➤ Try a Free Trial
Canada 1295614 ➤ Try a Free Trial
European Patent Office 0206459 ➤ Try a Free Trial
Germany 3686002 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Fuji
Cerilliant
Cantor Fitzgerald
Queensland Health
McKesson
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.